Skip to content

The Effectiveness of Vancomycin in Comarison With Cefazolin in Prevention of SSI After Craniotomy

The Effectiveness of Vancomycin in Comarison With Cefazolin in Prevention of SSI After Craniotomy

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03466645
Enrollment
126
Registered
2018-03-15
Start date
2018-04-01
Completion date
2019-08-01
Last updated
2018-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elective Craniotomy-candidated Patients

Keywords

SSI, elective Craniotomy, Vancomycin, Cefazolin, Antibiotic

Brief summary

Surgical-site infection is the most commonly reported nosocomial infection in patients undergoing surgery and 3rd most nosocomial infection in hospitalized patients. The SSI is associated with increases of length of hospitalization for 6 days and increases the hospital's cost by $ 300. Because of these, prevention of SSI with appropriate antibiotic is essential.

Interventions

DRUGVancomycin

The 1st group receives vancomycin an hour before craniotomy

DRUGCefazolin

The 2nd group receives cefazolin an hour before craniotomy

Sponsors

Isfahan University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age 18 years and above * elective surgical patients * No pre-surgery infection * Do not use antibiotics before surgery * Insensitivity to beta-lactam antibiotics

Exclusion criteria

* cranioplasty * Failure to follow the patient * The patient's unwillingness to continue participating in the research project * Death of the patient

Design outcomes

Primary

MeasureTime frameDescription
infection rateUntil 90 days after admissioncompare of infection rate in 2 groups

Secondary

MeasureTime frameDescription
raise of ESR & CRPUntil 90 days after admissioncompare the raise of ESR & CRP in 2 groups
length of hospitalizationUntil 90 days after admissioncompare the length of hospitalization in 2 groups

Countries

Iran

Contacts

Primary ContactRasool Mohammadi, Student
rasool.mohammadi1993@yahoo.com+989365725957

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026